Liječnički vjesnik (Jan 2023)

ModuLifeTM- a novel dietary approach in management of a patient with moderate Crohn’s disease

  • Alisa Fejzić,
  • Hana Franić,
  • Ana Barišić,
  • Irena Karas

DOI
https://doi.org/10.26800/LV-145-supl2-CR58
Journal volume & issue
Vol. 145, no. Supp 2
pp. 75 – 75

Abstract

Read online

microbiota, host barrier function, innate immunity, and the Crohn’s disease (CD) is a chronic inflammatory bowel disease of unknown aetiology. Evidence demonstrate that a person’s diet could be implicated in the pathogenesis of CD. Therefore, there is a growing interest in the use of diet as treatment or adjuvant therapy for CD. ModuLife is a dietary approach based on the Crohn’s Disease Exclusion Diet (CDED) combined with a specific Partial Enteral Nutrition (PEN) formula, that aims to reduce exposure to dietary components hypothesized to negatively affect the microbiome, innate immunity and intestinal barrier.

Keywords